The Association between Serum Neutrophil Gelatinase-Associated Lipocalin and Depression in Patients with Type 2 Diabetes Mellitus

References

• Alexandru, I. A., Ghenoiu, I. E., Manolache, R. E., Lecu, R. A., & Gionea, M. I. (2021). P.303 augmenting strategies for treatment-resistant major depression using atypical antipsychotics. European Neuropsychopharmacology, 44, S40–S41. doi:10.1016/j.euroneuro.2021.01.064
   Web of Science ®Google Scholar
• Alvelos, M., Pimentel, R., Pinho, E., Gomes, A., Lourenço, P., Teles, M. J., … Bettencourt, P. (2011). Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clinical Journal of the American Society of Nephrology, 6(3), 476–481. doi:10.2215/CJN.06140710
   PubMed Web of Science ®Google Scholar
• Baumeister, H., Hutter, N., & Bengel, J. (2014). Psychological and pharmacological interventions for depression in patients with diabetes mellitus: An abridged Cochrane review. Diabetic Medicine, 31(7), 773–786. doi:10.1111/dme.12452
   PubMed Web of Science ®Google Scholar
• Botas, P., Delgado, E., Castaño, G., Diaz de Grenu, C., Prieto, J., & Diaz-Cadorniga, F. J. (2010). Comparison of the diagnostic criteria for diabetes mellitus, WHO-1985, ADA-1997 and WHO-1999 in the adult population of Asturias (Spain). Diabetic Medicine, 20(11), 904–908. doi:10.1046/j.1464-5491.2003.01006.x
   Google Scholar
• Campayo, A., Jonge, P. D., Roy, J. F., Saz, P., de La Cámara, C., Quintanilla, M. A., … Lobo, A. (2010). Depressive disorder and incident diabetes mellitus: The effect of characteristics of depression. American Journal of Psychiatry, 167(5), 580–589. doi:10.1176/appi.ajp.2009.09010038
   PubMed Web of Science ®Google Scholar
• Campionsmith, C. (2021). Recognition of depression. BMJ, 7181.
   Google Scholar
• Comijs, H. C., Marwijk, H., Mast, R., Naarding, P., Oude Voshaar, R. C., Beekman, A. T., & Smit, J. H. (2011). The Netherlands study of depression in older persons (NESDO); a prospective cohort study. Bmc Research Notes, 4. doi:10.1186/1756-0500-4-524
   PubMedGoogle Scholar
• Damman, K., Veldhuisen, D. V., Navis, G., Voors, A. A., & Hillege, H. L. (2014). Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. European Journal of Heart Failure, 10(10), 997–1000. doi:10.1016/j.ejheart.2008.07.001
   Google Scholar
• Balu, D. T., Carlson, G. C., Talbot, K., Kazi, H., Hill‐Smith, T. E., Easton, R. M., Birnbaum, M. J., Lucki, I. (2012). Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus, 22, 230–240.
   PubMed Web of Science ®Google Scholar
• Deursen, V. V., Damman, K., Voors, A. A., van der Wal, M. H., Jaarsma, T., van Veldhuisen, D. J., Hillege, H. L. (2013). Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. Circulation, 7(1), 35–42.
   PubMed Web of Science ®Google Scholar
• Eren, B., Ahin, M., & Şahin, M. (2010). The effect of depression on quality of life of patients with type II diabetes mellitus. Depression and Anxiety, 25(2), 98–106.
   Web of Science ®Google Scholar
• Eren, I., Erdi, O., & Sahin, M. (2008). The effect of depression on quality of life of patients with type 2 diabetes mellitus. Depression and Anxiety, 25, 98–106. doi:10.1002/da.20288
   PubMed Web of Science ®Google Scholar
• Golden, S. (2007). A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Current Diabetes Reviews, 3(4), 252–259. doi:10.2174/157339907782330021
   PubMedGoogle Scholar
• Green, A. J., Fox, K. M., & Grandy, S. (2012). Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 96(3), 313–318. doi:10.1016/j.diabres.2012.01.002
   PubMed Web of Science ®Google Scholar
• Hannestad, J., Dellagioia, N., & Bloch, M. (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: A meta-analysis. Neuropsychopharmacology, 36(12), 2452. doi:10.1038/npp.2011.132
   PubMed Web of Science ®Google Scholar
• Ikeda, K., Aoki, H., Saito, K., Muramatsu, Y., & Suzuki, T. (2003). Associations of blood glucose control with self-efficacy and rated anxiety/depression in type II diabetes mellitus patients. Psychological Reports, 92(2), 540–544. doi:10.2466/pr0.2003.92.2.540
   PubMed Web of Science ®Google Scholar
• Ip, J., Noçon, A. L., Hofer, M. J., Lim, S. L., Müller, M., & Campbell, I. L. (2011). Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. Journal of Neuroinflammation, 8(1), 124. doi:10.1186/1742-2094-8-124
   PubMedGoogle Scholar
• Jonge, P. D., Roy, J. F., Saz, P., Marcos, G., & Lobo, A. (2006). Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: Results from the ZARADEMP project. Diabetologia, 49(11), 2627–2633. doi:10.1007/s00125-006-0442-x
   PubMed Web of Science ®Google Scholar
• Karim, J., Weisz, R., Bibi, Z., & Ur Rehman, S. (2015). Validation of the eight-item Center for Epidemiologic Studies Depression Scale (CES-D) among older adults. Current Psychology, 34(4), 681–692. doi:10.1007/s12144-014-9281-y
   Web of Science ®Google Scholar
• Knol, M. J., Twisk, J., Beekman, A., Heine, R. J., Snoek, F. J., & Pouwer, F. (2006). Depression as a risk for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia, 49(5), 837–845. doi:10.1007/s00125-006-0159-x
   PubMed Web of Science ®Google Scholar
• Krishnadas, R., & Cavanagh, J. (2012). Depression: An inflammatory illness? Journal of Neurology and Psychiatry, 83(5), 495–502. doi:10.1136/jnnp-2011-301779
   Web of Science ®Google Scholar
• Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., … Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Li, H., Zuo, Y. M., Lei, Y. H., Xu, R. J., & Wang, Y. (2014). Modeling of diabetes mellitus-related depression. Neurophysiology, 46(1), 71–78. doi:10.1007/s11062-014-9408-7
   Web of Science ®Google Scholar
• Liu, Q., & Nilsen-Hamilton, M. (1995). Identification of a new acute phase protein. Journal of Biological Chemistry, 270(38), 22565–22570. doi:10.1074/jbc.270.38.22565
   PubMed Web of Science ®Google Scholar
• Medscape Diabetes & Endocrinology. European Association for the Study of Diabetes 2016 Annual Meeting; September 14, 2016.
   Google Scholar
• Kimbro, L. B., Mangione, C. M., Steers, W. N., Duru, O. K., McEwen, L., Karter, A., Ettner, S. L. (2014). Depression and all-cause mortality in persons with diabetes mellitus: Are older adults at higher risk? Results from the translating research into action for diabetes study. Journal of the American Geriatrics Society.
   PubMed Web of Science ®Google Scholar
• Mucha, M., Skrzypiec, A. E., Schiavon, E., Attwood, B. K., Kucerova, E., & Pawlak, R. (2011). Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proceedings of the National Academy of Sciences of the United States of America, 108(45), 18436–18441. doi:10.1073/pnas.1107936108
   PubMed Web of Science ®Google Scholar
• Nainggolan, L. Global study examines depression with diabetes. Medscape. September 15, 2016.
   Google Scholar
• Naudé, P. J. W., Eisel, U. L. M., Comijs, H. C., Groenewold, N. A., De Deyn, P. P., Bosker, F. J., … Oude Voshaar, R. C. (2013). Neutrophil gelatinase-associated lipocalin: A novel inflammatory marker associated with late-life depression. Journal of Psychosomatic Research, 75(5), 444–450. doi:10.1016/j.jpsychores.2013.08.023
   PubMed Web of Science ®Google Scholar
• Pan, A., Lucas, M., Sun, Q., van Dam, R. M., Franco, O. H., Manson, J. E., & Hu, F. B. (2010). Bidirectional association between depression and type 2 diabetes mellitus in women. Archives of Internal Medicine, 170(21), 1884. doi:10.1001/archinternmed.2010.356
   PubMedGoogle Scholar
• Petrus, J. W. N., Nyakas, C., Eiden, L. E., Ait‐Ali, D., van der Heide, R., Engelborghs, S., Luiten, P. G., De Deyn, P. P., den Boer, J. A., Eisel, U. L. (2012). Lipocalin 2: Novel component of proinflammatory signaling in Alzheimer’s disease. The FASEB Journal, 26(7), 2811–2823.
   PubMed Web of Science ®Google Scholar
• Pouwer, F., Tack, C. J., Geelhoed-Duijvestijn, P., Bazelmans, E., Beekman, A. T., Heine, R. J., & Snoek, F. J. (2011). Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: A randomised controlled trial. Diabetologia, 54(4), 741–748. doi:10.1007/s00125-010-2033-0
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. doi:10.1177/014662167700100306
   Web of Science ®Google Scholar
• Sahay, A., & Hen, R. (2007). Adult hippocampal neurogenesis in depression. Nature Neuroscience, 10(9), 1110. doi:10.1038/nn1969
   PubMed Web of Science ®Google Scholar
• Schram, M., Baan, C., & Pouwer, F. (2009). Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium. Current Diabetes Reviews, 5, 112–119. doi:10.2174/157339909788166828
   PubMedGoogle Scholar
• Vogelzangs, N., Duivis, H. E., Beekman, A., Kluft, C., Neuteboom, J., Hoogendijk, W., … Penninx, B. W. J. H. (2012). Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Translational Psychiatry, 2(2), e79. doi:10.1038/tp.2012.8
   PubMedGoogle Scholar